Atara Biotherapeutics Inc.

NASDAQ: ATRAHealthcare / Biotechnology / USA
20.43-1.00-4.67%Vol 776 4391Y Perf -51.38%
Jun 24th, 2019 16:00
BID20.37 ASK20.43
Open21.23 Previous Close21.43
Pre-Market- After-Trading20.43
 - -%  - -%
Target Price
35.00 
Analyst Rating
Strong Buy 1.25
Potencial %
71.32 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/-98 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/-99 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-100/-100/-99 
Income Ranking
 —    -
Market Cap (mil)946 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
1.09 
Earnings Date
7th Aug 2019

Today's Price Range

20.1721.50

52wk Range

20.1743.95

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-11.98%
3 Months
-44.03%
6 Months
-33.90%
1 Year
-51.38%
3 Years
-4.89%
5 Years
-

Name / TickerPriceChg.Chg.%
ATRA20.43-1.0000-4.67
AAPL198.58-0.2000-0.10
GOOG1 115.52-6.3600-0.57
MSFT137.780.81000.59
XOM76.95-0.7400-0.95
WFC46.27-0.6200-1.32
JNJ143.060.97000.68
FB192.601.46000.76
GE10.28-0.2000-1.91
JPM108.66-0.7800-0.71
Earnings HistoryEstimateReportedSurprise %
Q01 2019-1.48-1.442.70
Q04 2018-1.31-1.75-33.59
Q03 2018-1.18-1.29-9.32
Q02 2018-0.97-1.15-18.56
Q01 2018-0.93-1.05-12.90
Q04 2017-1.15-1.150.00
Q03 2017-1.03-1.020.97
Q02 2017-0.91-0.94-3.30
Earnings Per EndEstimateRevision %Trend
6/2019 QR-1.453.33Positive
9/2019 QR-1.359.40Positive
12/2019 FY-5.547.51Positive
12/2020 FY-5.316.84Positive
Next Report Date7th Aug 2019
Estimated EPS Next Report-1.45
Estimates Count5
EPS Growth Next 5 Years %-
Volume Overview
Volume776 439
Shares Outstanding (in ths.)46 321
Trades Count3 336
Dollar Volume13 694 023
Avg. Volume585 662
Avg. Weekly Volume909 498
Avg. Monthly Volume733 120
Avg. Quarterly Volume681 414
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (87.50 %)
6 (100.00 %)
5 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (12.50 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.25
Strong Buy
1.00
Strong Buy
1.00

Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing therapeutics for patients with serious life-threatening such as cancer, autoimmune and other viral diseases. The company achieves this through two groups of product candidates, such as allogenic or third-party derived antigen-specific T-cells and molecularly targeted biologics.

CEO: Pascal Touchon

Teplephone: +1 650 278-8930

Address: 611 Gateway Boulevard, South San Francisco 94080, CA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

100%0%

Bearish Bullish

68%32%

Bearish Bullish

51%49%

News